Insulin Resistance as a Risk Factor in Visceral and Neurological Disorders provides an overview on the risk factors for insulin resistance in visceral and neurological disorders. The book focuses on molecular mechanisms and signal transduction processes associated with the links. The comprehensive information in this monograph will not only help in the early detection of insulin resistance related visceral and neurological disorders, but also promote the discovery of new drugs which may block or delay onset in elderly patients. Understanding these processes is important not only for patients, caregivers and health professionals, but also for health policymakers who must plan for national resources.
1. Cover image - p. Cover 2. Title page - p. iii 3. Table of Contents - p. iii 4. Copyright - p. iv 5. Dedication - p. v 6. About the author - p. xi 7. Preface - p. xiii 8. Acknowledgments - p. xvii 9. List of abbreviations - p. xix 10. Chapter 1. Insulin resistance and obesity - p. 1 11. Chapter 2. Insulin resistance, diabetes, and metabolic syndrome - p. 71 12. Chapter 3. Insulin resistance and heart disease - p. 113 13. Chapter 4. Insulin resistance and sleep apnea - p. 157 14. Chapter 5. Insulin resistance and stroke - p. 207 15. Chapter 6. Insulin resistance and Alzheimer’s disease - p. 249 16. Chapter 7. Insulin resistance and Parkinson’s disease - p. 293 17. Chapter 8. Insulin resistance, dementia, and depression - p. 349 18. Chapter 9. Use of phytochemicals for the treatment of insulin resistance–linked visceral and neurological disorders - p. 385 19. Chapter 10. Summery and perspective for future research on insulin resistance and insulin resistance–linked visceral and neurological disorders - p. 439 20. Index - p. 463
Insulin Resistance as a Risk Factor in Visceral and Neurological Disorders provides an overview on the risk factors for insulin resistance in visceral and neurological disorders. The book focuses on molecular mechanisms and signal transduction processes associated with the links. The comprehensive information in this monograph will not only help in the early detection of insulin resistance related visceral and neurological disorders, but also promote the discovery of new drugs which may block or delay onset in elderly patients. Understanding these processes is important not only for patients, caregivers and health professionals, but also for health policymakers who must plan for national resources.
1. Cover image - p. Cover 2. Title page - p. iii 3. Table of Contents - p. iii 4. Copyright - p. iv 5. Dedication - p. v 6. About the author - p. xi 7. Preface - p. xiii 8. Acknowledgments - p. xvii 9. List of abbreviations - p. xix 10. Chapter 1. Insulin resistance and obesity - p. 1 11. Chapter 2. Insulin resistance, diabetes, and metabolic syndrome - p. 71 12. Chapter 3. Insulin resistance and heart disease - p. 113 13. Chapter 4. Insulin resistance and sleep apnea - p. 157 14. Chapter 5. Insulin resistance and stroke - p. 207 15. Chapter 6. Insulin resistance and Alzheimer’s disease - p. 249 16. Chapter 7. Insulin resistance and Parkinson’s disease - p. 293 17. Chapter 8. Insulin resistance, dementia, and depression - p. 349 18. Chapter 9. Use of phytochemicals for the treatment of insulin resistance–linked visceral and neurological disorders - p. 385 19. Chapter 10. Summery and perspective for future research on insulin resistance and insulin resistance–linked visceral and neurological disorders - p. 439 20. Index - p. 463
